ArticleCancer medicine2023

Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis.

William J Chapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.